Fri, Aug 29, 2014, 12:32 PM EDT - U.S. Markets close in 3 hrs 28 mins

Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • yassen_gregorivich yassen_gregorivich Dec 13, 2013 12:45 PM Flag

    Jetman/Arthur/Censored/Adamwang - only hurts Yahoo, not AEGR

    You morons don't realize that nobody listens to your ranting about how much you lost shorting AEGR and we don't care about your whining about losing your retirement savings on the short (which isn't possible since you can't short in a retirement account, but whatever).

    All you do is make people stop coming to the Yahoo board.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • They stop coming to the Yahoo board because of people like you with name calling and making up things that other people said, e.g. no one has said a word about insider selling except YOU. No one really thinks it is significant to comment about except YOU. You have nothing else to grasp onto so you say or speak for people with your own little made up self-righteous corrections. And if they leave this board it is because YOU don't want to hear the other side, and YOU have given bad advice ever since the stock went above 69. t

      • 1 Reply to jetmanbash
      • Here is an article published by Ms. Yang and her partner in regards to juxta's potential and then the market value of AEGR. They noted that with approximately 1300 patients put on juxta that should give the company a market cap of $2.2 billion. It is almost there now with only about 300 patients on juxta. Thus the stock is ahead of itself you follow their metrics. Way ahead of itself IMO. Here's the article for your perusal. t

        http://seekingalpha.com/article/695631-physician-survey-results-on-lomitapide-and-mipomersen-support-our-thesis

 
AEGR
30.4401-0.1999(-0.65%)12:31 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.